Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folkavit C Plus is an over-the-counter (OTC) nutraceutical supplement developed and marketed by Kaviva Life Sciences, an Indian company that positions itself as a specialist in fertility and nutritional health. The product is part of the Folkavit brand line, which is generally formulated to support nutritional requirements related to reproductive health, prenatal care, and general wellness. Folkavit C Plus typically contains a combination of folic acid (Vitamin B9) and Vitamin C (ascorbic acid), and may include other micronutrients such as zinc. Folic acid is essential for DNA synthesis and red blood cell production, while Vitamin C acts as a potent antioxidant and a necessary cofactor for collagen synthesis. As a consumer nutraceutical, Folkavit C Plus is sold directly to consumers and does not have a formal pharmaceutical development pipeline or associated clinical trial phases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Folkavit C Plus.